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Objectives: To determine the role of Smad1 in bone development and postnatal bone formation.
Methods: Col2a1-Cre transgenic mice were bred with Smad1fx/fx mice to produce chondrocyte-speciﬁc
Smad1 conditional knockout (cKO) mice. Embryonic skeletal preparation and staining were performed,
alkaline phosphatase activity (ALP) and relative gene expressionwere examined in isolated primary cells.
Smad1fx/fx mice were also bred with Col1a1-Cre transgenic mice to produce osteoblast-speciﬁc Smad1 cKO
mice. Postnatal bone formation was assessed by micro-computed tomography (mCT) and histological
analyses in 2-month-old mice. Mineralized bone nodule formation assay, 5-bromo-20-deoxy-uridine
(BrdU) labeling and gene expression analysis were performed.
Results:Mice with chondrocyte- and osteoblast-speciﬁc deletion of the Smad1 gene are viable and fertile.
Calvarial bone development was delayed in chondrocyte-speciﬁc Smad1 cKO mice. In osteoblast-speciﬁc
Smad1 cKO mice, BMP signaling was partially inhibited and mice developed an osteopenic phenotype.
Osteoblast proliferation and differentiation were impaired in osteoblast-speciﬁc Smad1 cKO mice.
Conclusions: Smad1 plays an essential role in bone development and postnatal bone formation.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The vertebrate skeletal system is composed of two distinct
tissues: cartilage and bone. The variant cartilage types are connective
tissues important in numerous and varied roles during prenatal and
postnatal skeletal development1. Bones are rigid mineralized organs
formed in a variety of shapes. The cell type located in cartilage is the
chondrocyte and in bone the osteoblast and osteoclast. Chondrocytes
and osteoblasts are both originally derived from a common mesen-
chymal progenitor2, while osteoclasts have a hematopoietic origin.
There are twodifferentmechanismsof bone formation:membranous
bone formation and endochondral ossiﬁcation3e5 and both of these
mechanisms start with condensation of mesenchymal cells. During
endochondral ossiﬁcation most mesenchymal cells will differentiate
into chondrocytes and eventually these chondrocytes will be
replaced by osteoblasts and most bone tissues in the body are
developed through this process. In contrast, bones of the skull vault,o: D. Chen, Department of
iversity of Rochester Medical
, USA. Tel: 1-585-273-5631;
hen).
s Research Society International. Por cranium, and the clavicle form directly from mesenchymal
progenitors in a process termed membranous ossiﬁcation.
Prenatal and postnatal bone formation is a complicated process
that is regulated bymultiple growth factors, signalingmolecules, and
transcription factors. Sox9, Runx2 and b-catenin are important
transcription factors and a signaling protein, respectively, which
affect cell fate during early prenatal skeletal development. Sox9
inactivation in the cranial neural crest causes cranial neural crest-
derived cells to deviate from their chondrogenic differentiation into
an osteoblastic lineage6. Runx2-deﬁcient calvarial cells differentiate
into chondrocytes instead of osteoblastswhen culturedwith BMP-27.
Conditional inactivation of the b-catenin gene in mouse mesen-
chymal cells results in loss of osteoblasts and ectopic chondrocyte
formation in bone tissues through membranous and endochondral
bone formation processes8. During the postnatal stage, Ihh and
b-catenin play an important role in normal cartilage and bone
development. Postnatal conditional ablation of Ihh leads to condylar
disorganization and growth retardation9, while late stage postnatal
conditional activation of the b-catenin gene causes articular cartilage
degradation10.
BMPs, especially BMP-2, and their signaling proteins are required
in both chondrogenesis and bone formation at embryonic and
postnatal stages11e13. Smad1 is an immediate downstream trans-
ducing molecule of the BMP receptor and plays a central role in
mediating BMP signaling14. Activation of Smad1 is achieved throughublished by Elsevier Ltd. All rights reserved.
Table I
Breeding and production of Smad1Col2a1 mice
Breeding Desired progeny
a) Col2a1-Creþ/ Smad1fx/fx
b) Col2a1-Creþ/; Smad1fx/wt Smad1fx/fx
a) Col2a1-Creþ/; Smad1fx/wt
b) Col2a1-Creþ/; Smad1fx/fx
Table II
Breeding and production of Smad1Col1a1 mice
Breeding Desired progeny
a) CMV-Creþ/ Smad1fx/fx
b) Col1a1-Creþ/ Smad1del/wt
c) Col1a1-Creþ/; Smad1del/wt Smad1fx/fx
a) Smad1del/wt
b) Col1a1-Creþ/; Smad1del/wt
c) Col1a1-Creþ/; Smad1del/fx
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manner. Phosphorylated Smad1 thereafter forms a heteromeric
complex with Smad4. This heteromeric Smad complex translocates
and accumulates in the nucleus participating in gene transcription in
conjunction with other transcription factors. Smad1 is critical in
embryonic development. Targeted deletion of the Smad1 gene results
in early embryonic lethality due to failure of the allantois to fuse to
the chorion and animals die around embryonic day 10 (E10)15,16.
Since bone development starts at a later stage of embryonic devel-
opment and the ﬁrst ossiﬁcation center forms aroundE14.5 inmice17,
it is impossible to study the role of Smad1 in bone development and
subsequent bone formation postnatally using Smad1 knockout (KO)
mice.
Although an accumulating body of evidence shows that BMP
signaling is critical for chondrogenesis and osteoblast differentia-
tion, the physiological role of bone morphogenetic protein (BMP)
signaling in prenatal and postnatal bone formation in vivo remains
to be deﬁned. Recently, Retting et al. found that Smads 1 and 5 are
required for chondrogenesis by analyzing cartilage-speciﬁc Smad1
and Smad5 double KOmice18. However, the precise role of Smad1 in
prenatal bone development and postnatal bone formation remains
undeﬁned. In this study, we generated chondrocyte- and osteo-
blast-speciﬁc Smad1 cKO mice using the Cre-loxP system19e21 and
investigated the speciﬁc role of Smad1 in bone development and
postnatal bone formation. We found that chondrocyte-speciﬁc
deletion of the Smad1 gene causes ectopic cartilage formation in
calvaria at the embryonic stage, and further leads to delayed cal-
varial bone ossiﬁcation. Moreover, osteoblast-speciﬁc Smad1 cKO
mice have impaired postnatal bone formation. Our ﬁndings provide
direct evidence that Smad1 can regulate prenatal bone develop-
ment and postnatal bone formation.
Materials and methods
Generation of the Smad1 cKO Mice
To generate Smad1fx/fx mice, the Smad1 locus was targeted by
pLoxpneo-loxP-Smad1 inwhichexon2wasﬂankedwith loxP sites by
insertion of pLoxpneo in intron 1 and a third loxP site in intron 222.
Viablehomozygous Smad1fx/fxmicewereobtained, indicating that the
insertionofpLoxpneo in intron1doesnot interferewithexpressionof
the Smad1 gene. To generate chondrocyte-speciﬁc Smad1 cKO mice,
Smad1fx/fx mice were bred with Col2a1-Cre transgenic mice (Table I).
In these Smad1 cKO mice (hereafter referred to as Smad1Col2a1), the
Smad1 genewasdeletedbyCre recombinasewhichwasdrivenby the
3 kb murine type II collagen promoter (Col2a1-Cre)23. To determine
the role of Smad1 in postnatal bone formation, we also generated
osteoblast-speciﬁc Smad1 cKOmice. To facilitate the excision activity
of Cre, we bred Smad1fx/fx mice with CMV-Cre mice ﬁrst24 (Table II).
The strain of CMV-Cre mice mediates deletion of loxP-ﬂanked genes
in all tissues, including germ cells25. In this mouse line every single
cellwouldhave onlyoneﬂoxed Smad1 allele, removal ofwhichwould
result in compound heterozygosity for the deleted-null allele (CMV-
Cre;Smad1fx/wt). After that, we crossed Smad1del/wt mice with the
Col1a1-Cre transgenic mice in which Cre recombinase was driven by
the 2.3 kb murine osteoblast-speciﬁc type I collagen promoter26e28
(Table II). The 2.3 kb type I collagen promoter is mainly active in
mature osteoblasts29,30. Mating of these animals with mice homo-
zygous for the ﬂoxed allele (Smad1fx/fx) generated the progeny with
desired genotype, Col1a1-Cre;Smad1del/fx mice (osteoblast-speciﬁc
Smad1 cKO) (hereafter referred to as Smad1Col1a1). TheCre-dependent
recombination was detected by polymerase chain reaction (PCR)
[Fig. 2(B), Lane 1, 4 and 5].
The sequences of PCR primers for genotyping and detecting Cre
transgene are Cre-50, 50-CCT ggA AAA TgC TTC TgT CCg TTT gCC-30;Cre-30, 50-gAg TTg ATA gCT ggC Tgg Tgg Cag ATg-30, and the size of
the PCR product is 600-bp. The sequences of PCR primers for
genotyping Smad1fx/fxmice are SIF400, 50-gTT CCC ATT Tgg TTC CAA
gC-30; LoxP2, 50-gAg CTC TgC TCC gCC ACT CA-30. The 360-bp PCR
product was detected in wild-type mice and the 410-bp PCR
product was detected in Smad1fx/fx mice [Fig. 1(A)]. The sequences
of PCR primers for genotyping Smad1 cKO mice are S1F400, 50-gTT
CCC ATT Tgg TTC CAA gC-30; LoxP2, 50-gAg CTC TgC TCC gCC ACT CA-
30; Rec-Smad1, 50-CAC CTg TgC CCC CTC CAA gT-30. The 360-bp PCR
product was detected in wild-type mice, the 410-bp PCR product
was detected in Smad1fx/fx mice, and the 300-bp product was
detected after Smad1 recombination [Fig. 2(A)].
The Smad1-loxP, Col1a1-Cre and Col2a1-Cremice were produced
with mixed backgrounds22,23,26 and were then converted into C57
background in our lab after breeding with C57 mice for over
15 generations.
Isolation of calvarial mRNA from E16.5 embryos
E16.5 embryos were sacriﬁced and tail tissues were obtained for
genotyping. Calvarial tissues of E16.5 Smad1Col2a1 or Cre-negative
control embryos were harvested to obtain total mRNA. After
washing with sterile phosphate buffered saline (PBS) twice, the
calvariae were collected in 1.5 ml micro-centrifuge tubes. 1 ml
Trizol reagent (Qiagen) and one 5 mm stainless steal bead (Qiagen)
were added into each tube. This was followed by vibrating the tube
at 4C for 1 min using TissueLyser (Qiagen) to breakdown the
tissue. Total mRNA was harvested following Trizol manufacture’s
instructions. Expression of Col2a1, Cre and Smad1 mRNA was
analyzed by PCR or real-time PCR.
Embryonic skeletal alizarin red/alcian blue staining
Embryos were sacriﬁced at E16.5 and E18.5 and tail tissues were
obtained for genotyping. Embryo skin was removed before placing
them in 95% ethanol for 1e2 days to dehydrate. Embryos were then
transferred in acetone (J. T. Baker) for 1 day to remove fat. The alcian
blue/alizarin red staining was performed using a solution con-
taining 5 ml 0.3% alcian blue 8GS (Sigma) dissolved in 70% ethanol,
5 ml 0.1% Alizerin red S (Sigma) dissolved in 95% ethanol, 5 ml
glacial acetic acid (J. T. Baker), and 85 ml 70% ethanol in 37C
incubator for 3 days. The embryos were then transferred in 2% KOH
(Sigma) for 1e2 days until skeletons are clearly visible through the
surrounding skin. The embryos were transferred in 20% glycerin
(Sigma) containing 1% KOH, and ﬁnally store in 100% glycerin.
Assessment of three-dimensional (3D) trabecular microstructure
The calvariae of chondrocyte-speciﬁc Smad1 cKO embryos
(E16.5) and proximal tibiae of osteoblast-speciﬁc Smad1Col1a1
Fig. 1. Generation and analysis of Smad1Col2a1 mice. (A) Heterozygous Smad1 ﬂoxed mice (Smad1fx/wt) were bred with each other (Table I) and the production of homozygous Smad1
ﬂoxed mice (Smad1fx/fx) were identiﬁed by PCR using primers SIF400/LoxP2 (lower panel, Lane 1, 410-bp band). Smad1fx/fx mice were then bred with Co21a1-Cre mice (Table I, step
a and b) and Smad1Col2a1 mice were identiﬁed by PCR using Cre-50/Cre-30 primers (600-bp PCR product) and SIF400/LoxP2 primers (410-bp PCR product). (BeE) Total RNAs were
extracted from calvarial tissues of E16.5 Cre-negative and Smad1Col2a1 embryos. Expression of Col2a1 mRNA was detected in both Cre-negative and Smad1Col2a1 embryos and
expression of Cre mRNA was only detected in Cre-positive Smad1Col2a1 embryos. Expression of Smad1 mRNA was signiﬁcantly reduced in E16.5 Smad1Col2a1 embryos. (F) Chon-
drocyte-speciﬁc Smad1Col2a1 embryos and littermate control embryos are indistinguishable in size at embryonic day 16.5 (E16.5). Alizarin red/Alcian blue staining was performed on
E16.5 embryos. E16.5 Smad1Col2a1 embryos had delayed mineralization and ectopic cartilage formation of frontal [F] and parietal [P] bones compared to the same aged control
embryos. (G) Calvarial Alizarin red/Alcian blue staining showed delayed mineralization of supraoccipital [S] bone in E16.5 Smad1Col2a1 embryo. (H) The formation of ossiﬁcation
center of proximal phalangeal bone was also delayed in E16.5 Smad1Col2a1 embryos. (I and J) m-CT analysis showed reduced calvarial BV and mineralization in E16.5 Smad1Col2a1
embryos. Unpaired Student’s t-test, P¼ 0.045 (n¼ 3). (K) E18.5 Smad1Col2a1 embryos and littermate control embryos are indistinguishable in size. No delayed mineralization and
ectopic cartilage formation were observed in E18.5 Smad1Col2a1 embryos.
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tomography (mCT) scanner (mCT 40, Scanco Medical AG, Bas-
sersdorf, Switzerland) and Cre-negative littermates were used as
controls. A small X-ray tube with a mfocal spot is used as
a source. The detector consists of a linear charged coupled device
(CCD)-array. A scout view scan was obtained ﬁrst for selection of
the examination volume of the specimens, followed by auto-
matic positioning, measurement, and ofﬂine reconstruction32.
The ﬁeld of view was 30 mm 30 mm, and matrix size was
2048 2048. Images with isotropic resolution of 15 mm3 were
obtained.Alkaline phosphatase staining
Twenty-four hours after isolated from 3-day-old Cre-negative
and Smad1Col2a1 mice, primary calvarial osteoblasts were treated
with vehicle or BMP-2 (100 ng/ml) for 48 h. Prior to staining, cells
werewashedwith PBS andﬁxedwith 10%Neutral buffered formalin
(NBF) at 4C for 15 min. Cells were washed twice with milliQ H2O
after removal of NBF. Alkaline phosphatase (ALP) staining was per-
formed using a solution containing 66.7 ml 25 mg/ml naphthol AS-
MS-PO4 (Sigma) dissolved in N-N-Dimethylformamide (Sigma),
8.33 ml 0.2 M TriseHCl (pH¼ 8.3), 8.33 ml milliQ H2O, and 10 mg
Red Violet LB Salt in 37C incubator for 45 min.Isolation of primary sternal chondrocytes
Three-day-old neonatal pups were sacriﬁced and tail tissues were
obtained for genotyping. The anterior rib cage and sternum of
Smad1Col2a1 and Cre-negative control mice were harvested to obtain
sternal chondrocytes. This was followed by washing with sterile PBS
twice, and digestingwith 2 mg/ml pronase (Roche) dissolved in PBS in
a37Cwaterbathwithcontinuous shaking for60 min.The rib cageand
sternumwere then incubated in 3 mg/ml collagenase D (Roche) solu-
tion dissolved in serum-free Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (GIBCO)at37Cfor90 min.Thesoft tissuedebriswascarefully
removed. This was followed by further digestion in fresh 3mg/ml
collagenase D solution in petri dishes at 37C for 5 hwith intermittent
shaking. The digestion solutionwas ﬁltered using a 40 mmcell strainer
to collect the sternal chondrocytes. Cells were counted and plated in
complete DMEMwith 50 mg/ml ascorbic acid (Sigma).Isolation of primary calvarial osteoblasts
Three-day-old neonatal pupswere sacriﬁced and tail tissueswere
obtained for genotyping. Calvariae of 3-day-old Cre-negative and
Smad1Col2a1 mice were harvested to obtain calvariae. Calvariae were
washed with PBS twice, serum-free a-Minimum Essential Medium
(a-MEM) (GIBCO) twice, and thendigestedwith1 mg/ml Collagenase
Fig. 1. (continued).
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continuous shaking. Keep changing fresh 1 mg/ml Collagenase A
every 15e20 minutes for four times. On the 4th time digestion,
a 40 mm cell strainer was used to ﬁlter the digestion solution. Cells
were centrifuged and resuspended in complete aMEM (GIBCO) with
50 mg/mlAscorbicAcid (Sigma). The remaining calvariaewere further
digested twice with Collagenase A for 15e20 minutes each time to
collect digestion solution. Cells were centrifuged and resuspended
under the same condition.
Western blot analysis
The cells were lysed using Golden Lysis Buffer supplemented
with protease inhibitor cocktail tablets (Sigma). The Bio-Rad ProteinAssay (Bio-Rad) kit was used to detect protein concentration. The
protein was detected with mouse monoclonal antibody against
Smad1 (Santa Cruz) or phosphorylated Smad1/5/8. A monoclonal
antibody against b-actin (Sigma) at a dilution of 1:8000was used as
loading control. The immune complexes were detected using West
Pico chemiluminescent agents (Pierce).Histological and histomorphometric analyses
Histomorphometric analyses were performed on proximal tibial
metaphyses in 2-month-old osteoblast-speciﬁc Smad1Col1a1 mice
and control littermates that had been injected intraperitoneally
with calcein 7 and 2 days before animals were sacriﬁced28,31. Half of
Fig. 2. Reduction in marker gene expression in sternal chondrocytes and calvarial cells derived from Smad1Col2a1 mice. (A) Primary sternal chondrocytes were isolated from 3-day-
old Cre-negative and Smad1Col2a1 mice and total RNAs were extracted from these cells. Expression of genes related to chondrocyte differentiation and was measured by real-time
PCR. Signiﬁcant reduction in expression of these genes was observed in Smad1-deﬁcient cells. Unpaired Student’s t-test, Col2a1, P¼ 0.033; Col10a1, P¼ 0.005; Runx2, P¼ 0.012; ALP,
P¼ 0.048; Osterix, P¼ 0.004; OC, P¼ 0.080; Mmp13, P¼ 0.022 (Cre-negative, n¼ 6; Smad1Col2a1, n¼ 4). (B) Primary calvarial cells were isolated from 3-day-old Cre-negative and
Smad1Col2a1 mice and total RNAs were extracted from these cells. Expression of genes related to osteoblast differentiation and mineralization was measured by real-time PCR.
Unpaired Student’s t-test, Col2a1, P¼ 0.005; Runx2, P¼ 0.001; Alp, P¼ 0.452; Osterix, P< 0.001; OC, P¼ 0.002;Mmp13, P¼ 0.032 (Cre-negative, n¼ 6; Smad1Col2a1, n¼ 4). (C) Primary
calvarial cells were isolated from 3-day-old Smad1Col2a1 and their littermate control mice. Cells were treated with vehicle or BMP-2 (100 ng/ml) for 24 h, followed by ALP staining.
Smad1-deﬁcient cells had decreased basal ALP activity. BMP-2 stimulated ALP activity in control cells but had no effect on Smad1-deﬁcient cells.
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enediaminetetraacetic acid (EDTA), embedded in parafﬁn, and
sections stained with H&E or for tartrate-resistant acid phospha-
tase (TRAP). Histological changes in trabecular bones were
analyzed and changes in osteoblast and osteoclast numbers were
quantiﬁed as previously described28,31. The other half of the bone
samples were embedded in methylmethacrylate and sections used
for measurements of bone formation rates (BFR) or stained with
von Kossa to determine changes in the trabecular bone minerali-
zation and changes in bone volume (BV). Trabecular BV was
quantiﬁed in the bone marrow cavity 0.5e2.5 mm from the growth
plates and expressed as a percentage of total tissue volume (TV).
Values were expressed as the mean standard error calculated
from three non-consecutive sections per mouse from each of 10Smad1Col1a1 mice and littermate control mice. The calcein labeled
bone surface or mineralizing surface (MS) and the distance
between two ﬂuorescent labels was measured and BFR/bone
surface (BS), (mm3/mm2/day), were calculated.
5-bromo-20-deoxy-uridine (BrdU) labeling
BrdU labelingwas performedusing ZymedBrdU labeling reagent
and BrdU staining kit according to the manufacture’s protocols
(Zymed). Brieﬂy, BrdUwas injected intraperitoneally intomice 24 h
before sacriﬁce. Bone tissues were ﬁxed in 10% NBF and embedded
in parafﬁn. 3e4 mm thick sections were cut and placed on poly-
lysine coated slides. Slides were dried in a 60C oven overnight,
deparafﬁnized in two changes of xylene for 5 min each, and then
Fig. 3. Generation and analysis of Smad1Col1a1mice. (A and B) Smad1del/wt mice were bred with Col1a1-Cremice and Col1a1-Cre;Smad1del/wt mice were identiﬁed by PCR using Cre-50/
Cre-30 primers (lower panel, Lane 1, 4, 5, 600-bp PCR product) and Rec-Smad1/LoxP2 primers (300-bp PCR product). Heterozygous Smad1 null allele mediated by CMV-Cre was
detected by Rec-Smad1/LoxP2 primers. To generate osteoblast-speciﬁc Smad1Col1a1 mice, the Col1a1-Cre;Smad1del/wt mice were bred with Smad1fx/fx mice. The desired progeny,
Col1a1-Cre;Smad1del/fx mice (Smad1Col1a1 mice), were identiﬁed by PCR using SIF400/LoxP2 primers (tail tissue: 410-bp PCR product), Cre-50/Cre-30 primers (600-bp PCR product)
and Rec-Smad1/LoxP2 primers (300-bp PCR product). (C and D) Expression of Smad1mRNA and protein was measured by real-time PCR and Western blotting in bone marrow cells.
Expression of Smad1mRNAwas reduced about 80%. Unpaired Student’s t-test, P< 0.001 (n¼ 3). Expression of Smad1 protein was detected byWestern blotting using an anti-Smad1
monoclonal antibody in bone marrow cells derived from control mice but signiﬁcantly reduced in those derived from Smad1Col1a1 mice. (E and F) BV was analyzed in a deﬁned area
0.5e2.5 mm from the growth plate in proximal tibiae of 2-month-old Smad1Col1a1 mice and littermate control mice. The BV was normalized to TV. A 30% decrease in BV was
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according to manufacture’s protocols. Streptavidin-peroxidase was
used as a signal generator for the BrdU system and deaminobenzi-
dine in the presence of hydrogenperoxidewas used as a chromogen.
BrdU-incorporated nuclei were stained in a dark brown color34.
Mineralized bone nodule formation assay
Primary osteoblasts isolated from the calvariae of neonatal
Smad1Col1a1 mice and littermate control mice were used for
mineralized bone nodule formation assays as described previ-
ously28,31,33. Cells were plated in 24-well culture plates at a density
of 2104 cells/well and cultured with aMEM supplemented with
10% fetal calf serum (FCS). When cells reached conﬂuence (day 0),
the medium was changed to aMEM containing 5% FCS, 100 mg/ml
ascorbic acid and 5 mM b-glycerol phosphate with or without
addition of 100 ng/ml of BMP-2. The medium was changed every
other day and fresh reagents were added. After 10-day incubation,
von Kossa staining was performed to analyze the formation of
mineralized bone nodules.
Luciferase assay
Primary osteoblasts isolated from Smad1Col1a1 and Cre-negative
control mice were transiently transfected with BMP signaling
reporter construct 12 SBE-OC-Luc followed by treatment with 4,
20 and 100 ng/ml of BMP-2 using Superfect (Qiagen, CA, USA)
according to the manufacturer’s instruction. The DNA to transfection
reagent ratiowas 1:3 (w/w) in all experiments. b-gal plasmidwas co-
transfected as an internal control. Cells were lysed using passive lysis
buffer (Promega, WI, USA) and extracts were prepared to detect the
luciferase activity using the Dual Luciferase Assay System (Promega,
WI, USA) following manufacturer’s directions.
Statistical analysis
The datawere presented asmean 95% conﬁdence limit (CL). For
comparison of two groups of data, unpaired student’s t-test was
performed. For comparison of multiple groups of data, one-way
analysis of variance (ANOVA) was performed followed by Dunnett’s
test. *P< 0.05 was considered as signiﬁcant difference between two
experimental groups.
Results
Todetermine the roleof Smad1 in skeletal development, E16.5 and
E18.5 chondrocyte-speciﬁc Smad1Col2a1 embryos were analyzed. We
ﬁrst extracted RNA from calvarial tissues of E16.5 Cre-negative and
Smad1Col2a1 embryos to determine if Col2a1 gene is expressed and
Cre-recombination occurs in calvarial tissues of Smad1Col2a1 embryos.
We detected Col2a1 and Cre mRNA expression in calvariae of Cre-
negative and Smad1Col2a1 embryos [Fig.1(B andC)].We then analyzed
Smad1 expression and found that Smad1 expressionwas signiﬁcantly
reduced (about 70% reduction) in the calvaria of Smad1Col2a1 mice
[Fig. 1(D and E)]. These ﬁndings indicate that mouse calvarial tissues
indeed express the Col2a1 gene at early developmental stage.
Embryos were placed in 95% ethanol for 2 days for dehydration and
thenplaced inacetone for1 day to remove fat. Alizarin red/Alcianblue
staining was performed. Smad1Col2a1 embryos and their littermate
Cre-negative embryos are similar in size [Fig. 1(F)]. Delayedobserved in Smad1Col1a1 mice compared with littermate controls. Unpaired Student’s t-test, P
mice, the distance between the two labels was signiﬁcantly reduced as indicated by white arr
growth plates of proximal tibiae and expressed as mm3/mm2/day (F). Unpaired Student’s t-t
quantitated and a 19% decrease in osteoblast numbers was found in Smad1Col1a1 mice. Unpossiﬁcation of frontal, parietal and supraoccipital boneswas observed
in chondrocyte-speciﬁc Smad1Col2a1 embryos at E16.5 stage [Fig. 1(F
and G)]. In addition, formation of the ossiﬁcation center of proximal
phalangeal bones was also delayed in E16.5 Smad1Col2a1 embryos
[Fig. 1(H)]. We also analyzed calvarial bone formation and minerali-
zation of E16.5 Smad1Col2a1 embryos by m-CT and found that calvarial
bone formation and mineralization were reduced in Smad1Col2a1
embryos [Fig. 1(I and J)]. However, no obvious difference was
observed in E18.5 Smad1Col2a1 embryos compared to same aged Cre-
negative embryos [Fig. 1(K)], indicating that the delayed calvarial
mineralization and ectopic cartilage formation observed at E16.5
Smad1Col2a1 embryos are stage-speciﬁc phenomenon.
To further characterize these mice, we isolated primary sternal
chondrocytes and primary calvarial cells from 3-day-old chon-
drocyte-speciﬁc Smad1Col2a1 mice and Cre-negative control mice.
We analyzed the expression of genes related to calvarial bone
formation and mineralization and ALP activity. We found that
several of chondrocyte and osteoblast differentiation-related genes
were down-regulated in Smad1Col2a1 mice [Fig. 2(A and B)] and ALP
activity in calvarial cells was reduced [Fig. 2(C)]. It seems that
transition from cartilage to bone phase at the speciﬁc develop-
mental stage is delayed in Smad1Col2a1 mice and Smad1-mediated
BMP signaling plays an important role in this process.
To determine the role of Smad1 in postnatal bone formation, we
have generated osteoblast-speciﬁc Smad1Col1a1mice. The Smad1Col1a1
mice are viable, fertile, and survive into adulthood. To determine the
expression of Smad1 mRNA and protein, we isolated bone marrow
cells from 2-month-old Smad1Col1a1 mice and control littermates.
Expression of Smad1 mRNA was reduced about 80% in Smad1Col1a1
cells [Fig. 3(C)]. Smad1 protein expression was detected by Western
blotting using an anti-Smad1 mouse monoclonal antibody (Santa
Cruz, CA, USA) in osteoblasts derived from control mice. In Smad1-
Col1a1 cells, expression of Smad1 protein was signiﬁcantly reduced
[Fig. 3(D)]. These results demonstrate that expression of the Smad1
gene is disrupted in bone marrow cells in osteoblast-speciﬁc
Smad1Col1a1mice. To determine changes in trabecular bone formation
between Smad1Col1a1mice and littermate controls, 2-month-oldmice
were analyzed using histology and mCT methods on proximal tibial
metaphyses32. BV wasmeasured on von Kossa-stained tibia sections.
Compared to the Cre-negative control mice, the trabecular BV of
2-month-old osteoblast-speciﬁc Smad1Col1a1 mice was reduced 30%
[Fig. 3(E and F)]. To investigate the dynamic changes in bone
formation in Smad1Col1a1 mice, we measured BFR by performing
calcein/calcein labeling experiments. Fluorescent labels were
administered by intraperitoneal injection of calcein 7 and 2 days
before mice were sacriﬁced28,31. Undecalciﬁed bone tissues were
processed by methylmethacrylate embedding. A signiﬁcant reduc-
tion (36%) in BFR was found in osteoblast-speciﬁc Smad1Col1a1 mice
[Fig. 3(G and H)]. Since trabecular BV and BFR represent the
percentage of bone in a well-deﬁned area of bone marrow cavities
these results suggest that Smad1Col1a1 mice developed osteopenia.
We also analyzed bone mass in the heterozygous Smad1Col1a1 mice
and found that there is no signiﬁcant reduction in bonemass in those
heterozygous Smad1Col1a1 mice (data not shown).
mCT analysis conﬁrmed trabecular BV per unit of metaphyses to
be signiﬁcantly decreased in osteoblast-speciﬁc Smad1Col1a1 mice
[Fig. 4(A)]. Similarly, trabecular number (Th.N), trabecular thickness
(Tb.Th), and connectivity density (CD) were signiﬁcantly decreased
in Smad1 cKOmice comparedwith Cre-negative controls [Fig. 4(B, C
and E)]. Trabecular separation (Tb.Sp) and structure model index¼ 0.006 (n¼ 6). (G and H) The animals were labeled with calcein/calcein. In Smad1Col1a1
ows. The BFR/BS were measured in the area of the marrow cavity 0.5e2.5 mm from the
est, P¼ 0.004 (n¼ 6). (I) Osteoblast numbers in trabecular bone in the same area were
aired Student’s t-test, P < 0.001 (n¼ 6).
Fig. 4. m-CT analysis of Smad1Col1a1 mice. m-CT images showed a signiﬁcant reduction in bone mass in Smad1Col1a1 mice. (A) Trabecular structural parameters in the secondary
spongiosa of the proximal tibia were measured using mCT analysis. Samples were examined with an isotropic resolution of 5-mm voxel size. Tb.N (B), Tb.Th (C) and trabecular
connectivity density (Conn D) (E) were signiﬁcantly decreased in Smad1Col1a1 mice compared with littermate controls. Trabecular separation (Tb.Sp) (D) and SMI (F) were
signiﬁcantly increased in Smad1Col1a1 mice. Unpaired Student’s t-test; Tb.N., P¼ 0.047; Tb.Th., P¼ 0.001; Tb.Sp., P¼ 0.007; Conn D, P¼ 0.012; SMI, P< 0.001 (n¼ 6).
M. Wang et al. / Osteoarthritis and Cartilage 19 (2011) 751e762758(SMI) were signiﬁcantly higher in Smad1Col1a1 mice [Fig. 4(D
and F)]. These results suggest that trabecular BV and mechanical
property of the bone are reduced in Smad1Col1a1 mice.
To determine if there were changes in osteoblast number, we
quantiﬁed osteoblast number in the trabecular bone area of mouse
tibiae and found a 19% decrease in Smad1 cKO mice compared with
Cre-negative control mice [Fig. 3(I)]. No obvious changes in osteo-
clast numbers were observed in Smad1Col1a1 mice. To determine
whether osteoblast proliferation was affected, BrdU labeling exper-
iments were performed28. BrdU was injected intraperitoneally into
mice 24 h before sacriﬁce. Bone tissues were then processed and
stained. A signiﬁcant decrease (22%) in BrdU-positive osteoblasts
was found on calvarial bone surfaces in Smad1Col1a1 mice [Fig. 5(A
and B)]. These results demonstrate that defects in bone formation in
osteoblast-speciﬁc Smad1Col1a1 mice may be partially due to the
impairment of osteoblast proliferation.
To determine changes in osteoblast differentiation, primary
osteoblasts were isolated from the calvariae of neonatal Smad1Col1a1
mice and Cre-negative control mice and were used to examine
mineralized bone nodule formation8,31,33. The mineralized bone
nodules were formed at day 10 and treatment with BMP-2 (100 ng/
ml) stimulated the nodule formation in osteoblast cells derived from
control mice [Fig. 5(C, left panels)]. However, either at basal levels or
withBMP-2 treatment, nodule formationwas inhibited inosteoblasts
derived from Smad1Col1a1 mice [Fig. 5(C, right panels)]. To determine
if BMP signaling is blocked in osteoblasts derived from Smad1Col1a1
mice, we transfected the BMP signaling reporter construct 12 SBE-OC-Luc8 into primary osteoblasts of Smad1Col1a1 mice and Cre-nega-
tive control mice followed by BMP-2 treatment. In osteoblasts
derived from Smad1Col1a1 mice, BMP signaling was signiﬁcantly
inhibited compared with that in osteoblasts from Cre-negative
control mice [Fig. 5(D)]. We also analyzed osteoblast maker gene
expression34 and found that expression of osteoblast marker genes
such as Runx2, osterix, bone sialoprotein (BSP) and osteocalcin was
signiﬁcantly reduced in osteoblasts derived from Smad1Col1a1 mice
compared with those from Cre-negative control mice [Fig. 6(AeD)].
These results demonstrate that BMP signaling and osteoblast differ-
entiation are impaired in osteoblast-speciﬁc Smad1Col1a1 mice. To
determine if Smad5/8 phosphorylation is impaired in Smad1Col1a1
mice, we performed Smad5/8 phosphorylation assay. We found that
BMP-2-induced Smad5/8 phosphorylation remains intact in Smad1-
Col1a1 cells although the levelswere reduced compared to control cells
[Fig. 6(E)]. Our previous study demonstrates that b-catenin could act
upstream of BMP signaling35. To determine if deletion of the Smad1
gene could inhibit b-catenin signaling in osteoblasts, we treated
osteoblasts derived Cre-negative and Smad1Col1a1 mice with BIO,
a GSK-3b inhibitor, which mimics the activation of b-catenin
signaling. We found that BIO signiﬁcantly up-regulated ALP activity
in control cells. In contrast, its stimulatory effect was signiﬁcantly
reduced in Smad1Col1a1 cells [Fig. 6(F)]. These results suggest that
BMP-Smad1 could serve as downstream signaling molecules of
b-catenin signaling in osteoblasts. Since BMP signaling was not
completely blocked in osteoblasts derived from Smad1Col1a1mice, the
results suggest that BMP signaling through Smad5 or Smad8 remains
Fig. 5. Inhibition of osteoblast proliferation and differentiation in Smad1Col1a1 mice. (A and B) Parafﬁn-embedded sections of calvariae were stained with BrdU. The BrdU-positive
osteoblasts were indicated by red arrows and a 22% reduction of BrdU-positive osteoblasts was found in Smad1Col1a1 mice. Unpaired Student’s t-test, P¼ 0.002 (n¼ 4). (C) Primary
osteoblasts isolated from Smad1Col1a1 mice and littermate control mice were cultured for 10 days in the absence or presence of BMP-2 (100 ng/ml). von Kossa staining was per-
formed after the cell culture was ended and the formation of mineralized bone nodules was analyzed. In osteoblasts derived from Smad1Col1a1 mice, the formation of mineralized
bone nodules was inhibited. (D) Primary osteoblasts isolated from Smad1Col1a1 mice and littermate control mice were transfected with BMP signaling reporter construct 12 SBE-
OC-Luc and treated with 4, 20 and 100 ng/ml of BMP-2. The luciferase activity was measured and normalized to b-gal activity. In osteoblasts derived from Smad1 cKO mice, BMP
signaling was signiﬁcantly inhibited compared with cells isolated from littermate control mice. One-way ANOVA followed by Dunnett’s test, BMP-2 (4 ng/ml), P¼ 0.003; BMP-2
(20 ng/ml), P¼ 0.014; BMP-2 (100 ng/ml), P< 0.001 (n¼ 3) between control and Smad1Col1a1 cells.
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loss of Smad1 function. Generation of Smad1/5 double KO mice or
Smad1/5/8 triple KO mice would be necessary to examine this possi-
bility and to clarify the individual contributions of Smad1, 5 and 8 to
BMPsignaling inpostnatal bone formationandadult bone remodeling.
Discussion
To determine the speciﬁc contribution of Smad1 in bone
development and postnatal bone formation, we have generated
chondrocyte- and osteoblast-speciﬁc Smad1 cKO mice using
Col2a1-Cre (the Cre transgene is driven by the 3 kb Col2a1 trans-
gene) and Col1a1-Cre (the Cre transgene is driven by the 2.3 kb
Col1a1 promoter) transgenic mice. Our ﬁndings demonstrate
a delay in calvarial bone mineralization and reduction of postnatal
bone formation in these Smad1 cKO mice. Abzhanov et al. showed
that type II collagen is expressed in mouse calvaria during the
embryonic stage and large population of calvarial cells are derived
from Col2a1-positive chondrocyte-like cells36. In the paper pub-
lished by Ovchinnikov et al.23, the authors analyzed b-gal activity
at E15 embryos of Col2a1-Cre transgenic mice and they found
Col2a1 promoter activity is active in the axial and appendicular
skeleton, calvarial bones (temporal and basioccipital bones), and
the other elements of the skull. Our results show that chon-
drocyte-speciﬁc deletion of the Smad1 gene causes a transient
ectopic cartilage phase and delayed ossiﬁcation of the calvarial
bones during the prenatal stage. Our previous studiesdemonstrate that hypertrophic marker genes such as ColX and Alp
are upregulated by Wnt3a in primary chondrocytes. Activation of
Wnt/b-catenin signaling up-regulated Bmp-2 and Bmp4 expres-
sion and addition of noggin, a BMP antagonist, inhibited Wnt3a-
induced chondrocyte differentiation37. In the present study, we
further demonstrated that BIO-induced ALP activity was inhibited
in Smad1-deﬁcient cells. These ﬁndings suggest that BMP/Smad1
signaling is downstream of Wnt/b-catenin signaling in osteo-
blasts. Interestingly, ectopic cartilage formation in calvariae was
also observed when the b-catenin gene was inactivated8, and
these results suggest that the disruption of the b-catenin-BMP/
Smad1 signaling pathway may be responsible for the inhibition of
osteoblast differentiation in calvariae.
Cumulative evidence shows that intact BMP signaling is neces-
sary for postnatal bone formation. Our previous studies demon-
strate that disruption of normal BMP signaling by expressing
dominant-negative type I BMP receptor causes osteopenic pheno-
type28. Tob is a member of anti-proliferative protein family and
inhibits BMP-induced and Smad-dependent transcription in oste-
oblasts by direct inhibition of Smad1 or 538. Tob KO mice show
increased BMP signaling and enhanced responsiveness to BMP-2-
induced osteoblast proliferation and differentiation. Bonemass and
BMP-2-induced local bone formation are increased in Tob KO
mice38,39. These observations demonstrate that Smad1 and other
BMP-activated Smad proteins play an important role in postnatal
bone formation. The importance of BMP signaling in postnatal bone
formation is reinforced by studies using transgenic mice in which
Fig. 6. Reduction in expression of osteoblast marker genes in Smad1Col1a1 mice. (AeD) mRNA expression of osteoblast marker genes was examined by real-time PCR. The expression
of Runx2, Osterix (Osx), BSP and osteocalcin (D) genes was signiﬁcantly decreased in osteoblasts derived from Smad1Col1a1 mice. Unpaired Student’s t-test; Runx2, P¼ 0.002; Osterix,
P¼ 0.022; BSP, P¼ 0.050; OC, P¼ 0.002 (n¼ 6). (E) Primary osteoblasts were starved for 12 h and then treated with BMP-2 (100 ng/ml) for 6 h. Smad1/5/8 phosphorylation was
measured by Western blotting using an anti-p-Smad1/5/8 antibody. BMP-2-induced Smad1/5/8 phosphorylation was reduced in Smad1-deﬁcient cells. (F) Primary osteoblasts were
treated with BIO (1 mM) for 48 h and ALP activity in cell lysates was measured. Signiﬁcant inhibition of ALP activity was found in Smad1-deﬁcient cells. One-way ANOVA followed by
Dunnett’s test, basal ALP, P¼ 0.127; BIO, P< 0.001 (n¼ 3), between control and Smad1-deﬁcient cells.
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osteoblasts. In these mice, osteopenic and osteoporotic phenotypes
were observed40e42. These ﬁndings provide evidence that activa-
tion of endogenous BMP signaling can enhance bone formation and
that regulation of the amount of BMP signaling in postnatal life is
required for normal bone formation. Our current ﬁndings are
consistent with previous observations in Bmpr1a cKO mice. Dele-
tion of the Bmpr1a gene in mature osteoblasts targeted by the Og2-
Cre transgenic mice showed reduced BV and BFR in 3-month-old
cKO mice43. However, when the Bmpr1a gene is deleted in early
progenitor cells using the 3.2Col1-CreER transgenicmice, bonemass
was increased in the cKO mice44. The different phenotypes of these
mice may be due to targeting different populations of cells at
different stages. In our study, we used 2.3Col1-Cre transgenic mice
which target mature osteoblasts population similar to Og2-Cre
transgenic mice and found similar osteopenic phenotype. Although
both Smad1 and Smad5 are expressed in primary osteoblasts and
multiple osteoblast-like cell lines, such as 2T3 and MC3T3 cells
(data not shown), our present ﬁndings suggest that Smad1 is one of
the critical molecules mediating BMP signaling and regulating
postnatal bone formation. To fully understand the BMP signaling in
postnatal bone formation, osteoblast-speciﬁc deletion of the
Smad1/5 genes or Smad1/5/8 genes will be required.
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